510(k) Report

510(k) · Cleared

Cleared

Ponto Plus and Ponto Plus Power

K132775510(k) TraditionalCleared Dec 9, 201395-day reviewClass II21 CFR 874.3302

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Oticon Medical AB · LXB Hearing Aid, Bone Conduction

Cleared on Dec 9, 2013 as substantially equivalent to K090996 (Oticon Medical AB, 2009) and 1 other predicate after a 95-day review. Its family tree reaches back 7 generations to 1986. 10 later devices descend from it.

Decided
Dec 9, 2013
Review
95 days
Class
Class II
Product code
LXB
Recalls
None
Predicates
2

Its longest line of descent runs back 7 generations to K861971 (1986). 20 ancestors in all. 10 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2009: 1 other ancestor2008: 2 other ancestors2004: 1 other ancestor2002: 1 other ancestor2001: 1 other ancestor1999: 1 other ancestor1998: 1 other ancestor1994: 1 other ancestor1993: 1 other ancestor1995: 1 other ancestor1991: 1 other ancestor1987: 1 other ancestor2016: 2 descendants cleared2015: 2 descendants cleared2021: 3 descendants cleared2019: 1 descendant cleared2018: 1 descendant cleared2026: 1 descendant clearedK861971 · Xomed Audiant Bone Conductor W/Improved AA Coil · Xomed, Inc. · 1986K955713 · Nobelpharma Bone Anchored Hearing Aid · Nobelpharma USA, Inc. · 1996×2: 2 generations cleared close together, K984162 (1999), K992872 (1999) K080363 · Baha Cordelle II · Cochlear Bone Anchored Systems AB · 2008K090720 · Cochlear Baha BP100 · Cochlear Bone Anchored Systems AB · 2009K103594 · Ponto Pro Power · Oticon Medical AB · 20111990200020102020
  1. Root · 7 generations backK861971 Xomed Audiant Bone Conductor W/Improved AA CoilXomed, Inc. · 1986
  2. 6 generations backK955713 Nobelpharma Bone Anchored Hearing AidNobelpharma USA, Inc. · 1996
  3. 5 generations backK984162 Branemark Bone-Anchored Hearing Aid (Baha) System for Pediatric UseNobelpharma USA, Inc. · 1999
  4. 4 generations backK992872 Branemark Bone-Anchored Hearing Aid (Baha) Cordelle IIEntific Medical Systems, Inc. · 1999
  5. 3 generations backK080363 Baha Cordelle IICochlear Bone Anchored Systems AB · 2008
  6. 2 generations backK090720 Cochlear Baha BP100Cochlear Bone Anchored Systems AB · 2009
  7. 1 generation backK103594 Ponto Pro PowerOticon Medical AB · 2011
  8. This deviceK132775 Ponto Plus and Ponto Plus PowerOticon Medical AB · 2013
  9. Descendant · cites it directly · 5 of its ownK161671 Ponto 3, Ponto 3 Power and Ponto 3 SuperPowerOticon Medical AB · 2016
  10. Descendant · 2 generations on · 3 of its ownK190540 Ponto 4Oticon Medical AB · 2019
  11. Descendant · cites it directly · 3 of its ownK142678 Ponto Bone Anchored Hearing system/ Abutment, 14mm. Ponto Bone…Oticon Medical AB · 2015
  12. Descendant · 3 generations on · 2 of its ownK211640 Ponto 5 MiniOticon Medical AB · 2021
  13. Descendant · 2 generations on · 1 of its ownK213733 Ponto 5 SuperPowerOticon Medical AB · 2021

Showing 5 of 10 descendants. See all descendants

Descendants cleared per year

2015: 22016: 22018: 12019: 12021: 32026: 1
2015high 3 (2021) · low 0 (2017)2026

Most influential descendants

Showing 5 of 10 · See all
  • K161671Ponto 3, Ponto 3 Power and Ponto 3 SuperPowerOticon Medical AB · 2016 · cites it directly5descendants
  • K190540Ponto 4Oticon Medical AB · 2019 · 2 generations on3descendants
  • K142678Ponto Bone Anchored Hearing system/ Abutment, 14mm. Ponto Bone Anchored Hearing System /…Oticon Medical AB · 2015 · cites it directly3descendants
  • K211640Ponto 5 MiniOticon Medical AB · 2021 · 3 generations on2descendants
  • K213733Ponto 5 SuperPowerOticon Medical AB · 2021 · 2 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K861971Xomed Audiant Bone Conductor W/Improved AA CoilXomed, Inc.1986—
−6K955713Nobelpharma Bone Anchored Hearing AidNobelpharma USA, Inc.1996—
−5K984162Branemark Bone-Anchored Hearing Aid (Baha) System for Pediatric UseNobelpharma USA, Inc.1999—
−4K992872Branemark Bone-Anchored Hearing Aid (Baha) Cordelle IIEntific Medical Systems, Inc.1999—
−3K080363Baha Cordelle IICochlear Bone Anchored Systems AB2008—
−2K090720Cochlear Baha BP100Cochlear Bone Anchored Systems AB2009—
−1K103594Ponto Pro PowerOticon Medical AB2011—
0 (this device)K132775Ponto Plus and Ponto Plus PowerOticon Medical AB2013—
+1K161671Ponto 3, Ponto 3 Power and Ponto 3 SuperPowerOticon Medical AB2016—
+2K190540Ponto 4Oticon Medical AB2019—
+1K142678Ponto Bone Anchored Hearing system/ Abutment, 14mm. Ponto Bone Anchored…Oticon Medical AB2015—
+3K211640Ponto 5 MiniOticon Medical AB2021—
+2K213733Ponto 5 SuperPowerOticon Medical AB2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
199110
199310
199410
199510
199810
199910
200110
200210
200410
200820
200910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201520
201620
201810
201910
202130
202610
FIG. 1 — Lineage of K132775, 1986–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LXB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LXB device

  1. #1 K254296 Ossiclear (Ossiclear System)score 14.7 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K090996Ponto Pro
Summary page 1
…roduct codes LXB, MAH) Predicate Devices Deic - S ) n. Maufcu- r Ponto bone anchored hearing system K090996 (Ponto Pro) Oticon Medical AB Ponto bone anchored hearing system K103594 (Ponto Pro Power) Oticon Medical AS…
Oticon Medical AB2009—
*K103594Ponto Pro Power
Summary page 1
…) n. Maufcu- r Ponto bone anchored hearing system K090996 (Ponto Pro) Oticon Medical AB Ponto bone anchored hearing system K103594 (Ponto Pro Power) Oticon Medical AS Air conduction hearing aid Exempt from 510Ok. Oticon A/S === Pa…
Oticon Medical AB2011—

Also cleared against K090996: 2 other devices →

What descends from it? (10)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K161671Ponto 3, Ponto 3 Power and Ponto 3 SuperPowerOticon Medical AB20165
K142678Ponto Bone Anchored Hearing system/ Abutment, 14mm. Ponto Bone Anchored Hearing System /…Oticon Medical AB20153

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 5 companies; a new generation was cleared every 2.5 years on median.
  • None of the 20 ancestors has a recall.
  • Of its descendants, K161671 (Oticon Medical AB, 2016) has gone furthest, with 5 descendants of its own.
  • 2 other devices also cite its predicate K090996.

How does its category compare?

All LXB devices

LXB Hearing Aid, Bone Conduction: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · LXB

2in 2025

2008: 22009: 22010: 22011: 52012: 12013: 52015: 22016: 42017: 12018: 12019: 12021: 42025: 22026 (partial year): 4
2007high 5 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LXB

79in 2021

2011: 189 days median2013: 103 days median2016: 110 days median2021: 79 days median2026 (partial year): 164 days median
2007high 189 (2011) · low 79 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LXB

1in 2018

2012: 52018: 1
2007high 5 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LXB

261in 2025

2007: 42008: 1102009: 762010: 912011: 1232012: 3462013: 6402014: 5452015: 8242016: 6922017: 3792018: 3362019: 4972020: 5472021: 4902022: 3872023: 3482024: 2322025: 261
2007high 824 (2015) · low 4 (2007)2025

MAUDE reports naming product code LXB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—04
20082—0110
20092—076
20102—091
201151890123
20121—5346
201351030640
20140—0545
20152—0824
201641100692
20171—0379
20181—1336
20191—0497
20200—0547
20214790490
20220—0387
20230—0348
20240—0232
20252—0261
202641640—

What is it indicated for?

The Ponto Plus and Ponto Plus Power are intended for the following patients and indications: * Patient with conductive or mixed hearing losses, who can still benefit from amplification of the sound. The pure tone average (PTA) bone conduction (BC) threshold (measured at 0.5, 1, 2 and 3 kHz) of the indicated ear should be better than or equal to 45 dB HL for use with the Ponto Plus sound processor, 55 dB HL for use with the Ponto Plus Power sound…

Read the full statement (308 words)

The Ponto Plus and Ponto Plus Power are intended for the following patients and indications:

* Patient with conductive or mixed hearing losses, who can still benefit from amplification of the sound. The pure tone average (PTA) bone conduction (BC) threshold (measured at 0.5, 1, 2 and 3 kHz) of the indicated ear should be better than or equal to 45 dB HL for use with the Ponto Plus sound processor, 55 dB HL for use with the Ponto Plus Power sound processor.

* Bilateral fitting is applicable for most patients having a symmetrically conductive or mixed hearing loss. The difference between the left and right sides' BC thresholds should be less than 10 dB on average measured at 0.5, 1, 2 and 4 kHz, or less than 15 dB at individual frequencies.

* Patients who have a profound sensorineural hearing loss in one ear and normal hearing in the opposite ear (i.e. single sided deafness or "SSD"). The pure tone average (PTA) air conduction (AC) threshold of the hearing ear should then be better than or equal to 20 dB HL (measured at 0.5, 1, 2 and 3 kHz).

* Also indicated for any patient who is indicated for an air-conduction contralateral routing of signals (AC CROS) hearing aid, but who for some reason cannot or will not use an AC CROS.

The placement of a bone anchored implant is contraindicated for patient below the age of 5.

The Ponto Plus and Ponto Plus Power sound processors are intended to be used with either the Ponto implant system or with specific compatible BAHA abutments/implants from Cochlear Bone Anchored Solutions (BAS) (refer to the Ponto Plus labeling for specific compatible Cochlear models). In addition, selected Cochlear Baha sound processors can be used with the Ponto implant/abutment system (refer to the Ponto labeling for compatible Baha sound processor models).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K132775: Ponto Plus and Ponto Plus Power.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K132775

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026